BioCentury
ARTICLE | Clinical News

Calypte regulatory update

August 12, 1996 7:00 AM UTC

The FDA licensed CALY's HIV-1 Urine EIA enzyme immunoassay to detect antibodies to HIV-1 in urine. CALY will sell the test directly to 12 U.S.-based laboratories, while Seradyne (Indianapolis, Ind.) h...